Stroke is the second leading cause of death worldwide. There is a real need to develop treatment strategies for reducing neurological deficits in stroke survivors, and stem cell (SC) therapeutics appear to be a promising alternative for stroke therapy that can be used in combination with approved thrombolytic or thrombectomy approaches. However, the efficacy of SC therapy depends on the SC homing ability and engraftment into the injury site over a long period of time. Nonetheless, tracking SCs from their niche to the target tissues is a complex process.
CITATION STYLE
Nucci, M. P., Filgueiras, I. S., Ferreira, J. M., Oliveira, F. A. de, Nucci, L. P., Mamani, J. B., … Gamarra, L. F. (2020). Stem cell homing, tracking and therapeutic efficiency evaluation for stroke treatment using nanoparticles: A systematic review. World Journal of Stem Cells, 12(5), 381–405. https://doi.org/10.4252/wjsc.v12.i5.381
Mendeley helps you to discover research relevant for your work.